Блог им. gtcapital

SPY на премаркете стоит в узком коридоре после гэпа вниз

Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.00

Блог им. gtcapital: SPY на премаркете стоит в узком коридоре после гэпа вниз

DATA смотрим на продажу ниже 70

SPLK продажа ниже 59.50

NKE смотрим на продолжение роста

COST смотрим на покупку выше 127

NXPI покупка выше 71

Gapping up/down: MGAM +28% following merger with GCA, RAX +5% on M&A reports, FEYE +3% after upgrade; CPB -3% after earnings, UK stocks under pressure, F-2% after dg

Gapping up
In reaction to strong earnings/guidance: XCRA +2.1%

M&A news: MGAM +28.7% (to be acquired by Global Cash Access (GCA) for $36.50/share in cash), RAX +4.7% (CenturyLink (CTL) considering acquisition of RAX, according to reports)

Other news: MSTX +11.1% (announces positive top line results from Phase 2 study of AIR001), ISNS +7.3% (co and NuPark LLC announced that they have completed an integration and partnership agreement), ASTI +6.8% (files for 1 mln share common stock offering by selling shareholders), ALLT +5.1% (receives an expansion order of $15 mln from a Tier-1 Operator), HTZ +3.3% (announces Mark Frissora to step down as Chairman and CEO), BCRX +3.1% (announces RAPIVAB trial results for the treatment of influenza), YHOO +2.9% (rising in advance of BABA IPO release, also positive commentary on Mad Money), GLUU +2.7% (discloses it extended its licensing agreement with Kim Kardashian by three years), HIMX +1.9% (Google Glass on sale in GOOG Play store), NVAX +1.7% (presents data on RSV F Nanoparticle vaccine induced monoclonal antibody), GTAT +1.1% (Former GTAT employee Paul Matthews claims that GTAT sapphire covers are in AAPL iPhone 6, according to reports), SYN +1.1% (highlights SYN-005 data; SYN-005 neutralizing antibody combination protects against pertussis in murine and non-human primate models)


Analyst comments: INFN +4.6% (upgraded to Buy from Hold at Jefferies), FEYE +3.2% (upgraded to Buy from Neutral at UBS), MTRX +2.2% (upgraded to Buy from Hold at KeyBanc Capital Mkts), SGI +1.9% (upgraded to Buy at DA Davidson; tgt raised to $12), BAC +0.9% (upgraded to Buy from Neutral at Goldman), UBNT +0.9% (initiated with an Outperform at FBN Securities), TSLA +0.7% (initiated with an Outperform at FBN Securities), AIG +0.6% (initiated with a Buy at Citigroup)

Gapping down
In reaction to disappointing earnings/guidance: CPB -3.2%.

Select UK listed names showing weakness following sell-off in FTSE: LYG -4.7%, RBS -4.3%, GSK -3.7%, BCS -3.5%, AZN -2.4%, RDS.A -1.9%, HSBC -1.9%, BP -1.8%, SHPG -1.6%, RIO -1.5%, ING -1.3%

Other news: WRLD -7.7% (disclosed KPMG would not respond to recent request for proposal to serve as independent registered public accounting firm), DGLY -5.9% (cont volatility), AKS -3.4% (announces concurrent offerings of 35 mln shares common stock and senior unsecured notes with aggregate value of $430 mln), XON -2.9% (files mixed securities shelf offering), UEC -2.2% (files shelf offering for ~1.86 mln shares of common stock ), TKMR -1.7% (negative mention on Mad Money)

Analyst comments: KERX -6% (downgraded to Underperform at FBR Capital ), F -2.5% (downgraded to Underweight at Morgan Stanley), HMY -2.5% (initiated with a Neutral at JP Morgan), GOLD -1.6% (initiated with a Neutral at JP Morgan)

Оригинал статьи: gtstocks.com/analytics-08-09-2014.html

теги блога GT Capital

....все тэги



UPDONW
Новый дизайн